Site Search
Search Results
Cancer Advocates Urge California Governor to Sign Legislation Expanding Access to Biomarker Testing Needed for Many Innovative Treatments
Sacramento, Calif. – The California Legislature passed a bill last night that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which ... was introduced by Senator Monique Limón (D-Santa Barbara) – has received unanimous, bipartisan support throughout the legislative process. Biomarker testing is a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
Patient Advocates Rally in Times Square for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Legislation
... Earlier today, cancer survivors gathered in Times Square alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on Governor Hochul to sign Senate Bill 1196a / Assembly Bill 1673a and reject any attempts to weaken the bill by limiting its scope. Biomarker testing enables physicians to match patients with personalized care and improve patient quality of life by avoiding ineffective, invasive ...
Calls to Improve New Yorkers’ Access to Precision Medicine Through Biomarker Testing Bring Together Patients and Providers from across Disease Spectrum
... seeks to improve New Yorkers’ access to precision medicine, requiring all state-regulated health plans, including Medicaid, to cover biomarker testing when it is supported by medical and scientific evidence. Over 60 organizations have rallied together in support of the legislation, citing the efficacy of and praising the innovation in precision medicine. Biomarker testing is a tool utilized by physicians across a variety of specialties to connect patients to the right treatment at the right time. ...
Survivor Views of Pharmacogenomic Testing
... at all levels of government. Fielded June 26-July 19, 2023, our latest survey explores awareness of and attitudes toward pharmacogenomic (PGx) testing, a form of genetic testing to better understand a patient’s risk for drug reactions. The web-based survey was conducted among 1,155n cancer patients and survivors ... same drug. These differences may impact the effectiveness of a drug or the side effects a person may experience. (Note: this is different from biomarker testing of a tumor to help determine which drug may be used) Four-in-Ten Aware of PGx Testing Based on the definition above, 42% of ...
Texas Becomes Latest State to Improve Access to Biomarker Testing, Beating New York in Push to Prioritize Precision Medicine
... TX – MAY 30, 2023 – Yesterday, Texas Governor Greg Abbott signed Senate Bill 989 into law, making Texas the 11 th state to expand access to biomarker testing. New York is considering comparable legislation through Assembly Bill 1673 / Senate Bill 1196. The American Cancer Society Cancer Action ... responded to the legislative victory in Texas with the following statement: “Texas has joined a growing list of states expanding access to biomarker testing. The clock is ticking for New York to do the same. We cannot wait any longer to act on Assembly Bill 1673 / Senate Bill 1196. ...
Thank You to Our 2023 Lights of Hope Sponsors!
We could not accomplish the critical cancer advocacy work that we do without the generosity of our sponsors. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid. ...
Victory for Public Health: ACS CAN Applauds Decision to Reject Flawed Biomarker Legislation
... CAN) in West Virginia: "The American Cancer Society Cancer Action Network (ACS CAN) applauds the Senate for not supporting House Bill 4753, the biomarker testing legislation, which was supposed to allow West Virginians to get the testing they need and not fall farther behind other states. West Virginia patients deserve access to proven and necessary biomarker tests that can allow them to benefit from the right treatments at the right time – often leading to improved health outcomes, better ...
New Survey: Top Barriers to Biomarker Use in Cancer Care Include Coverage and Cost Concerns
... Network (ACS CAN) released new survey data today examining some of the most common barriers providers face in performing recommended cancer biomarker testing. The survey of 315 oncology providers found lab turnaround time was the greatest challenge to biomarker testing (41%), followed by patient concerns about out-of-pocket costs (39%) and insurance coverage of biomarker tests (37%). The majority ...
Cancer Advocates Commend Colorado Lawmakers for Positive First Step in Opening Door to Precision Medicine
... Cancer Society Cancer Action Network (ACS CAN) applauds the Colorado General Assembly for taking a great first step to increasing access to biomarker testing by passing SB24-124. The bill was met with strong bi-partisan support in both the House and Senate. With the legislative process now ... enacted, the policy would help connect more patients diagnosed with cancer or other diseases with the right treatment at the right time through biomarker testing . The bill would ensure more patients with private insurance will have health insurance coverage for the biomarker testing they ...
Georgia General Assembly Passes Bill That Could Improve Cancer Survivorship by Expanding Access to Biomarker Testing, Necessary First Step in Personalizing Treatment
... 2023 – After a final vote by the Senate, the Georgia General Assembly today passed a bill (HB 85) that is expected to provide more access to biomarker testing, which is testing that can help physicians to identify the most effective treatment for a patient’s disease. Revolutionizing cancer treatment over the last few decades, biomarker testing can provide access to targeted treatment; tailoring care to a person’s individual disease. Targeted therapies often result in ...
Type
- Action (20) Apply Action filter
- Basic page (47) Apply Basic page filter
- Blog Post (1) Apply Blog Post filter
- Event (21) Apply Event filter
- Press Release (139) Apply Press Release filter
- Resource (14) Apply Resource filter
- State Priority (32) Apply State Priority filter
- Update (6) Apply Update filter
- Webform (3) Apply Webform filter
Priority Issue
State
- New York (23) Apply New York filter
- Pennsylvania (22) Apply Pennsylvania filter
- California (15) Apply California filter
- Ohio (15) Apply Ohio filter
- Colorado (11) Apply Colorado filter
- Washington (11) Apply Washington filter
- Florida (10) Apply Florida filter
- Kentucky (10) Apply Kentucky filter
- Maine (10) Apply Maine filter
- Connecticut (9) Apply Connecticut filter
- Georgia (8) Apply Georgia filter
- Illinois (7) Apply Illinois filter
- Maryland (7) Apply Maryland filter
- Massachusetts (7) Apply Massachusetts filter
- Indiana (6) Apply Indiana filter
- National (6) Apply National filter
- New Jersey (6) Apply New Jersey filter
- Texas (6) Apply Texas filter
- West Virginia (6) Apply West Virginia filter
- Iowa (5) Apply Iowa filter
- Minnesota (5) Apply Minnesota filter
- Arizona (4) Apply Arizona filter
- Hawaii (4) Apply Hawaii filter
- Michigan (4) Apply Michigan filter
- Nevada (4) Apply Nevada filter
- New Hampshire (4) Apply New Hampshire filter
- New Mexico (4) Apply New Mexico filter
- North Carolina (4) Apply North Carolina filter
- Oklahoma (4) Apply Oklahoma filter
- Tennessee (4) Apply Tennessee filter
- Vermont (4) Apply Vermont filter
- Oregon (2) Apply Oregon filter
- Rhode Island (2) Apply Rhode Island filter
- Alaska (1) Apply Alaska filter
- Arkansas (1) Apply Arkansas filter
- Louisiana (1) Apply Louisiana filter
- Mississippi (1) Apply Mississippi filter
- Montana (1) Apply Montana filter
- South Dakota (1) Apply South Dakota filter
- Utah (1) Apply Utah filter